Assertio Holdings (ASRT) Change in Inventory (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Change in Inventory came in at -$912000.0 in Q1 2026, down 155.85% year-on-year from $1.6 million in Q1 2025, and down 236.12% quarter-over-quarter from $670000.0 in Q4 2025.
Assertio Holdings (ASRT) Change in Inventory (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Change in Inventory across 8 years of filings, most recently posting -$912000.0 for Q1 2026.
- Change in Inventory for Q1 2026 came in at -$912000.0, down 155.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.2 million (down 237.77% YoY), and the FY2025 annual result was -$9.7 million, down 200.99% from the prior year.
- Change in Inventory came in at -$912000.0 for Q1 2026 at Assertio Holdings, down from $670000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $3.6 million in Q1 2023 to a low of -$7.6 million in Q3 2025.
- The 5-year median for Change in Inventory is $2.0 million (2022), against an average of $621117.6.
- Across the five-year window, Change in Inventory surged 289.28% in 2022 and slumped 518.92% in 2025, its largest moves.
- Assertio Holdings' Change in Inventory stood at -$1.0 million in 2022, then slumped by 287.08% to -$3.9 million in 2023, then jumped by 163.67% to $2.5 million in 2024, then plunged by 73.19% to $670000.0 in 2025, then plunged by 236.12% to -$912000.0 in 2026.
- The last three Change in Inventory figures came in at -$912000.0 (Q1 2026), $670000.0 (Q4 2025), and -$7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -93.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 114.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -4.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 20.30 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -2.11 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | -912,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -912,000.00 |
| Mar 31, 2026 | -912,000.00 |
| Dec 31, 2025 | 670,000.00 |
| Dec 31, 2025 | 670,000.00 |
| Sep 30, 2025 | -7.60 Mn |
| Sep 30, 2025 | -7.60 Mn |
| Jun 30, 2025 | -4.39 Mn |
| Jun 30, 2025 | -4.39 Mn |
| Mar 31, 2025 | 1.63 Mn |
| Mar 31, 2025 | 1.63 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Sep 30, 2024 | 1.81 Mn |
| Sep 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | 2.93 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Mar 31, 2024 | 2.34 Mn |
| Dec 31, 2023 | -3.93 Mn |
| Dec 31, 2023 | -3.93 Mn |